Back to Search
MARISSA MEISSNER, M.D.
M.D.
Rheumatology Physician
NPI: 1518258227IndividualAccepts Medicare
Education
UNIVERSITY OF TEXAS MEDICAL SCHOOL AT SAN ANTONIO
Class of 2011
Research & Publications (20)
Inhibition of Rac1 GTPase downregulates vascular endothelial growth factor receptor-2 expression by suppressing Sp1-dependent DNA binding in human endothelial cells.
PMID 19469899·Exp Dermatol·2009
8-other
What new cell biology findings could bring to therapeutics: is it time for a phenome-project in Toxoplasma gondii?
PMID 19430642·Mem Inst Oswaldo Cruz·2009
6-review
Down-regulation of vascular endothelial growth factor receptor 2 is a major molecular determinant of proteasome inhibitor-mediated antiangiogenic action in endothelial cells.
PMID 19223539·Cancer Res·2009
8-other
CIITA versus IFN-gamma induced MHC class II expression in head and neck cancer cells.
PMID 19104823·Arch Dermatol Res·2009
8-other
"I enjoyed your talk, but...": Evidence-based medicine and the scientific foundation of the American Venous Forum.
PMID 18945576·J Vasc Surg·2009
8-other
Microtubule-targeted drugs inhibit VEGF receptor-2 expression by both transcriptional and post-transcriptional mechanisms.
PMID 18323785·J Invest Dermatol·2008
8-other
Loss of interferon-gamma inducibility of the MHC class II antigen processing pathway in head and neck cancer: evidence for post-transcriptional as well as epigenetic regulation.
PMID 18284388·Br J Dermatol·2008
8-other
Mapping the future: organizational, clinical, and research priorities in venous disease.
PMID 18068564·J Vasc Surg·2007
6-review
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 100 N ACADEMY AVE
DANVILLE, PA 17822 - Phone
- (570) 275-5555
Quick Facts
- NPI
- 1518258227
- Entity Type
- Individual
- Gender
- Female
- Medicare
- Accepted
- Specialties
- 3
- Locations
- 1
- Years in Practice
- 15
- Publications
- 20
Are you this provider?
Claim Your Profile